76 237

Cited 0 times in

Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors ( Diabetes Metab J 2019;43:158-73)

DC Field Value Language
dc.contributor.author강은석-
dc.contributor.author이지연-
dc.date.accessioned2022-08-19T06:24:10Z-
dc.date.available2022-08-19T06:24:10Z-
dc.date.issued2019-06-
dc.identifier.issn2233-6079-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/189136-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Diabetes Association-
dc.relation.isPartOfDIABETES & METABOLISM JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCanagliflozin-
dc.subject.MESHGlucose-
dc.subject.MESHSodium-
dc.subject.MESHSodium-Glucose Transporter 2 Inhibitors*-
dc.subject.MESHSymporters*-
dc.titleResponse: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors ( Diabetes Metab J 2019;43:158-73)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorJi Yeon Lee-
dc.contributor.googleauthorEun Seok Kang-
dc.identifier.doi10.4093/dmj.2018.0106-
dc.contributor.localIdA00068-
dc.contributor.localIdA03197-
dc.relation.journalcodeJ00720-
dc.identifier.eissn2233-6087-
dc.identifier.pmid31210038-
dc.contributor.alternativeNameKang, Eun Seok-
dc.contributor.affiliatedAuthor강은석-
dc.contributor.affiliatedAuthor이지연-
dc.citation.volume43-
dc.citation.number3-
dc.citation.startPage379-
dc.citation.endPage380-
dc.identifier.bibliographicCitationDIABETES & METABOLISM JOURNAL, Vol.43(3) : 379-380, 2019-06-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.